BRL 36173
Latest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antibacterials; Penicillins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 28 Sep 1998 Discontinued-Preclinical for Bacterial infections in United Kingdom (Unknown route)
- 19 Oct 1994 No-Development-Reported for Bacterial infections in United Kingdom (Unknown route)